Put Down the ACE: Low Clinical Utility for Angiotensin-Converting Enzyme Levels in Sarcoidosis: A Single-Center Retrospective Cohort Study
2024

Low Clinical Utility for Angiotensin-Converting Enzyme Levels in Sarcoidosis

Sample size: 119 publication 10 minutes Evidence: moderate

Author Information

Author(s): Druyan Amit, Noam Shuv, Lidar Merav

Primary Institution: Sheba Medical Center

Hypothesis

What is the significance of elevated ACE levels in the diagnosis and follow-up of sarcoidosis patients?

Conclusion

ACE levels are a non-specific serological marker with low specificity and sensitivity for sarcoidosis and a poor positive predictive value.

Supporting Evidence

  • ACE levels had a positive predictive value of 12.76% and a negative predictive value of 94.6% for the diagnosis of sarcoidosis.
  • Elevated ACE levels correlated poorly with disease activity in the cohort.
  • Patients with elevated ACE levels were more likely to achieve drug-free remission.

Takeaway

Doctors often check ACE levels to see if someone has sarcoidosis, but this study shows that it doesn't really help much.

Methodology

A single-center retrospective cohort study using electronic patient records to analyze ACE levels in sarcoidosis patients.

Potential Biases

Potential bias due to the retrospective design and unknown reasons for ACE testing referrals.

Limitations

The study's retrospective nature limited control over all influencing factors, and asymptomatic manifestations were not thoroughly evaluated.

Participant Demographics

Patients with sarcoidosis had a mean age of 57.01 years, with 45.37% being male.

Statistical Information

P-Value

p<0.0001

Confidence Interval

IQR 25.75–67.5

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3390/jcm13247657

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication